Catalyst
Slingshot members are tracking this event:
Pacira (PCRX) Expects to Initiate Phase 4 Study in Q3 Evaluating EXPAREL in Pain from C-Section Transversus Abdominis Plane (TAP) Block
Do you think this event is important to the companies below? How will it affect their stock price?
Related Companies | Importance
|
Impact on Stocks
|
||||
---|---|---|---|---|---|---|
PCRX |
|
|
Slingshot Insights Explained
Catalyst Date
Occurred on:
Jun 05, 2017
Occurred Source:
https://clinicaltrials.gov/ct2/show/NCT03176459
Related Projects
-
Don’t see a project related to the catalyst you care about?
Related Keywords
Phase 4, Exparel, Pain, C-section, Tap, Transversus Abdominis Plane Block